Senior insider sale
SVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$787.5K
1.50K shares
What this filing means
TATSIS OURANIA plans to sell 1.50K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $787.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001959173-26-005073
Officer· SVP, CRO
Since Oct 2019
1.50K
Shares to sell
$787.5K
Approx. market value
1.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/17/2021
1.50KTotal acquired1.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2021 | Restricted Stock Vesting Compensation | 1.50K | — |
| Total | 1.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.50K
Market value
$787.5K
7/2/2026
Total
Units
1.50K
Value
$787.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2026 | 1.50K | $787.5K | NASDAQ | Planned |
| Total | 1.50K | $787.5K | ||